GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | October 09, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
7E5R | 7E5R | SARS-CoV-2 S trimer with three-antibody cocktail complex | |
7CAI | P0DTC2 | SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab | Spike glycoprotein, Light chain of H014 Fab, Heavy chain of H014 Fab |
7CAI | 7CAI | SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab | Spike glycoprotein, Light chain of H014 Fab, Heavy chain of H014 Fab |
7DF3 | P0DTC2 | SARS-CoV-2 S trimer, S-closed | Spike glycoprotein |
7DF4 | Q9BYF1 | SARS-CoV-2 S-ACE2 complex | Angiotensin-converting enzyme 2 (E.C.3.4.17.23,3.4.17.-), Spike glycoprotein |
7DF4 | P0DTC2 | SARS-CoV-2 S-ACE2 complex | Angiotensin-converting enzyme 2 (E.C.3.4.17.23,3.4.17.-), Spike glycoprotein |
8P99 | P0DTC2 | SARS-CoV-2 S-protein:D614G mutant in 1-up conformation | |
8C1V | P0DTC2 | SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map | |
8C1V | 8C1V | SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map | |
7LXZ | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region |
7LXZ | 7LXZ | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region |
7LXX | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
7LXX | 7LXX | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
7LY2 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2M28 Fab Heavy Chain variable region, S2M28 Fab Light Chain variable region |
7LY2 | 7LY2 | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2M28 Fab Heavy Chain variable region, S2M28 Fab Light Chain variable region |
7LY0 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | Spike glycoprotein, S2M28 Fab Light Chain variable region, S2M28 Fab Heavy Chain variable region |
7LY0 | 7LY0 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | Spike glycoprotein, S2M28 Fab Light Chain variable region, S2M28 Fab Heavy Chain variable region |
7LXY | P0DTC2 | SARS-CoV-2 S/S2M11/S2X333 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2X333 Fab Heavy Chain variable region, S2X333 Fab Light Chain variable region |
7LXY | 7LXY | SARS-CoV-2 S/S2M11/S2X333 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2X333 Fab Heavy Chain variable region, S2X333 Fab Light Chain variable region |
7LXW | P0DTC2 | SARS-CoV-2 S/S2M11/S2X333 Local Refinement | S2X333 Fab Light Chain variable region, S2X333 Fab Heavy Chain variable region, Spike glycoprotein |
7LXW | 7LXW | SARS-CoV-2 S/S2M11/S2X333 Local Refinement | S2X333 Fab Light Chain variable region, S2X333 Fab Heavy Chain variable region, Spike glycoprotein |
8F5I | Q6N882 | SARS-CoV-2 S2 helix epitope scaffold bound by antibody DH1057.1 | |
8F5I | 8F5I | SARS-CoV-2 S2 helix epitope scaffold bound by antibody DH1057.1 | |
7N62 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N62 | 7N62 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N64 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7N64 | 7N64 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7YDY | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab | |
7YDY | 7YDY | SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab | |
7YE5 | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs | |
7YE5 | 7YE5 | SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs | |
7YE9 | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs | |
7YE9 | 7YE9 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs | |
7YEG | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
7YEG | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
7YEG | 7YEG | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
7YDI | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
7YDI | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
7YDI | 7YDI | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
8YZ6 | P0DTC2 | SARS-CoV-2 Spike (BA.1) in complex with Fab of JH-8B | |
8YZ6 | 8YZ6 | SARS-CoV-2 Spike (BA.1) in complex with Fab of JH-8B | |
7NS6 | 7NS6 | SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies | |
7NS6 | P10104 | SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies | |
7NS6 | P0DTC2 | SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies | |
7A94 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound | Spike glycoprotein |
7A94 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound | Spike glycoprotein |
7KJ2 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | Spike glycoprotein |
7KJ2 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | Spike glycoprotein |
7KJ4 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound | Spike glycoprotein |
7KJ4 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound | Spike glycoprotein |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024